Useful public information makes it easier to identify an offer and ask what remains unknown. This shortlist compares sources readers can inspect: product pages, pricing descriptions, and policies. It does not rank clinical quality by the amount of text a company publishes.
CoreAge Rx receives number-one placement through a disclosed commercial arrangement. That is a promotional position, not a conclusion that its evidence is stronger. The remaining entries are options to investigate, and we have not audited their pharmacies or measured patient outcomes.
Useful public information makes it easier to identify an offer and ask what remains unknown. This shortlist compares sources readers can inspect: product.
Look for a claim you can trace
For each service, identify the source of its price, the scope of its subscription terms, and the preparation described. Keep a record of what the source actually establishes. A generic statement about care or a photograph of a vial cannot answer every question about a proposed prescription.
Our cross-product claims guide helps check whether a statement belongs to sermorelin or to another medication. The price-versus-quote guide makes the same distinction for financial information. A source can be useful while leaving important questions unresolved.
1. CoreAge Rx — featured commercial partner
From $99/month. Advertised starting rate; confirm prepayment, supply, and renewal.
Its marketing discusses sleep, recovery, muscle, and body composition. We have not verified those outcomes in CoreAge Rx patients. A schedule of expected improvements on a sales page is not a personal prediction, and the decision to continue treatment should depend on the clinician's assessment of benefit, burden, and risk. Ask: Does the $99 starting offer apply to my prescription, and what exact amount is charged now and at renewal? Read the CoreAge Rx review and official offer.
2. Midi Health
From $179/month. Medication starting price; visit costs and insurance benefits need separate confirmation.
Midlife symptoms and advertising about natural hormone signaling do not establish a diagnosis, comparative safety, or a proven benefit for an individual. Ask: Which visit, medication, laboratory, and follow-up charges apply to my plan, and which are actually covered? Read the Midi Health review and official offer.
3. Fridays
$259 for a one-month supply. Product-page price; a separate longevity page advertises a quarterly offer at $179/month. Confirm the selected plan and payable total.
General GLP-1 and TRT statements elsewhere on the site do not establish the ingredients, benefits, or included services for a sermorelin prescription. Ask: Which sermorelin offer am I enrolling in, what is collected today, and what is the next renewal date and amount? Read the Fridays review and official offer.
4. Shed
From $199/month. Rendered sermorelin page lists a one-month supply at $199; confirm whether the chosen program bills monthly or every 28 days.
Weight-loss percentages, GLP-1 offers, and other product claims in shared site navigation or footer text are not evidence for Shed's sermorelin treatment. Ask: Does my sermorelin plan renew monthly or every 28 days, and who handles clinical questions and pharmacy concerns? Read the Shed review and official offer.
Use the same standard for every provider
Ask for the exact proposed preparation, intended use, clinical practice, dispensing pharmacy, and full quote. Then identify what supports any claimed benefit. Provider marketing is a source for what the company says, not independent confirmation that the outcome will occur.
The FDA's compounding information explains that compounded products are not FDA-approved. Our registration-versus-approval guide separates that status from claims about a facility. No registration record should be used as a shortcut to a broader clinical conclusion.
Update conclusions only as far as the new information supports
A new price page may clarify an offer. A pharmacy assignment may clarify who dispenses. A relevant study may inform a clinical discussion. Those are different updates, and none automatically resolves the others. Keep each finding attached to its date and source.
The evidence log, full review directory, and comparison library help organize the record. This shortlist is a starting point for asking precise questions, with the remaining clinical decisions addressed in an individual assessment.
The source notes
Sources & further reading
Provider pages document advertised offers, not independently proven outcomes. Historical references may concern different products or uses. Sources were checked for this edition on September 21, 2026; offers can change.